Merck
  • 主页
  • 查找结果
  • Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.

Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.

International journal of radiation oncology, biology, physics (2013-02-26)
Joshua Schindel, Manickam Muruganandham, F Christopher Pigge, James Anderson, Yusung Kim
摘要

To present a novel marker-flange, addressing source-reconstruction uncertainties due to the artifacts of a titanium intracavitary applicator used for magnetic resonance imaging (MRI)-guided high-dose-rate (HDR) brachytherapy (BT); and to evaluate 7 different MRI marker agents used for interstitial prostate BT and intracavitary gynecologic HDR BT when treatment plans are guided by MRI. Seven MRI marker agents were analyzed: saline solution, Conray-60, copper sulfate (CuSO4) (1.5 g/L), liquid vitamin E, fish oil, 1% agarose gel (1 g agarose powder per 100 mL distilled water), and a cobalt-chloride complex contrast (C4) (CoCl2/glycine = 4:1). A plastic, ring-shaped marker-flange was designed and tested on both titanium and plastic applicators. Three separate phantoms were designed to test the marker-flange, interstitial catheters for prostate BT, and intracavitary catheters for gynecologic HDR BT. T1- and T2-weighted MRI were analyzed for all markers in each phantom and quantified as percentages compared with a 3% agarose gel background. The geometric accuracy of the MR signal for the marker-flange was measured using an MRI-CT fusion. The CuSO4 and C4 markers on T1-weighted MRI and saline on T2-weighted MRI showed the highest signals. The marker-flange showed hyper-signals of >500% with CuSO4 and C4 on T1-weighted MRI and of >400% with saline on T2-weighted MRI on titanium applicators. On T1-weighted MRI, the MRI signal inaccuracies of marker-flanges were measured <2 mm, regardless of marker agents, and that of CuSO4 was 0.42 ± 0.14 mm. The use of interstitial/intracavitary markers for MRI-guided prostate/gynecologic BT was observed to be feasible, providing accurate source pathway reconstruction. The novel marker-flange can produce extremely intense, accurate signals, demonstrating its feasibility for gynecologic HDR BT.

材料
货号
品牌
产品描述

Sigma-Aldrich
琼脂糖, BioReagent, for molecular biology, low EEO
Sigma-Aldrich
琼脂糖, Type I, low EEO
Sigma-Aldrich
硫酸铜, ReagentPlus®, ≥99%
Sigma-Aldrich
硫酸铜, anhydrous, powder, ≥99.99% trace metals basis
Sigma-Aldrich
二氯化钴, 97%
Sigma-Aldrich
琼脂糖, for molecular biology
Sigma-Aldrich
琼脂糖, Low EEO
Sigma-Aldrich
0.1 M 氯化钴 溶液
Sigma-Aldrich
琼脂糖, Ultra-low Gelling Temperature, molecular biology grade
Sigma-Aldrich
硫酸铜(II) 溶液, 4 % (w/v) (prepared from copper (II) sulfate pentahydrate)
Sigma-Aldrich
二氯化钴, purum p.a., anhydrous, ≥98.0% (KT)
Sigma-Aldrich
琼脂糖, Medium EEO, for molecular biology
Sigma-Aldrich
Sepharose® 4B, 45-165 μm bead diameter
Sigma-Aldrich
琼脂糖, Type I-A, low EEO
Sigma-Aldrich
琼脂糖, Ultra-low Gelling Temperature
Sigma-Aldrich
硫酸铜, puriss. p.a., anhydrous, ≥99.0% (RT)
Sigma-Aldrich
琼脂糖, Low EEO, for Immunoelectrophoresis
Sigma-Aldrich
琼脂糖, Type II-A, Medium EEO
Sigma-Aldrich
琼脂糖, High Gelling Temperature
Sigma-Aldrich
琼脂糖, High EEO, for molecular biology
Sigma-Aldrich
硫酸铜, puriss., meets analytical specification of Ph. Eur., BP, USP, anhydrous, 99-100.5% (based on anhydrous substance)
Sigma-Aldrich
Sepharose® 6B, 6% Beaded Agarose, 45-165 μm (wet), fractionation range 10,000-1,000,000 Da (dextrans)
Sigma-Aldrich
琼脂糖, Wide range, for molecular biology
Sigma-Aldrich
琼脂糖, High EEO
Sigma-Aldrich
二氯化钴, AnhydroBeads, −10 mesh, 99.9% trace metals basis
Sigma-Aldrich
琼脂糖, For pulsed field electrophoresis running gel
Sigma-Aldrich
琼脂糖, BioReagent, for molecular biology, Wide range/Standard 3:1
Sigma-Aldrich
二氯化钴, AnhydroBeads, −10 mesh, 99.995% trace metals basis
Sigma-Aldrich
琼脂糖, Special High EEO
Sigma-Aldrich
琼脂糖, Type IV, Special High EEO